This updated formulation is a bivalent vaccine that will combine the original vaccine with one that targets omicron sublineages BA.4 and BA.5.
Moderna submitted its application to the U.S. Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older, the company said in a news release on Tuesday.
"We have worked closely with the FDA to ensure that Americans will have access to Moderna's updated, bivalent booster, which, if authorized, may offer higher, broader, and more durable protection against COVID-19 compared to the currently authorized booster," said Stephane Bancel, chief executive officer of Moderna.
"FDA will be using the totality of the available evidence to authorize the fall bivalent boosters," FDA spokesperson Abigail Capobianco said in a statement emailed to CNN last week. "There are data on many millions of individuals who have received the prototype component as a booster. As for the BA.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna booster application goes to FDA for authorizationThis updated formulation is a bivalent vaccine that will combine the original vaccine with one that targets omicron sublineages BA.4 and BA.5.
Les mer »
Pfizer Seeks Approval for Updated COVID BoosterPfizer has sent an application to the FDA for emergency use authorization of its updated COVID-19 booster vaccine for the fall, the company announced Monday.
Les mer »
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorizationPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the FDA for emergency use authorization.
Les mer »
Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Les mer »
Moderna asks FDA to authorize its updated Covid booster shotThe reformulated booster targets the BA.5 omicron subvariant, currently dominant in the U.S. The Biden administration plans to roll out the shots in the fall.
Les mer »
Moderna Asks FDA to OK Updated BoostersModerna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its COVID-19 booster shot
Les mer »